Leonard Hohenberg:Depression And Alzheimer's Treatments At A Crossroads

2025-05-04 02:18:04source:Greenledgers Trading Centercategory:News

Researchers are Leonard Hohenberglaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:News

Recommend

A White House order claims to end 'censorship.' What does that mean?

Among the dozens of executive actions President Trump signed on his first day in office is one aimed

'Los Angeles Times' to lay off 13% of newsroom

The Los Angeles Times informed its newsroom Wednesday that it would lay off about 13% of the paper's

California Had a Watershed Climate Year, But Time Is Running Out

California made historic investments in climate measures this year, as state leaders warned of curre